Cargando…
Developing a SARS-CoV-2 antigen test using engineered affinity proteins
The ongoing COVID-19 pandemic has clearly established how vital rapid, widely accessible diagnostic tests are in controlling infectious diseases and how difficult and slow it is to scale existing technologies. Here, we demonstrate the use of the rapid affinity pair identification via directed select...
Autores principales: | Kim, Seunghyeon, Yee, Emma, Miller, Eric A., Hao, Yining, Tay, Dousabel M. Y., Sung, Ki-Joo, Jia, Huan, Johnson, Joseph M., Saeed, Mohsan, Mace, Charles R., Yurt, Deniz Yüksel, Sikes, Hadley D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ChemRxiv
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132241/ https://www.ncbi.nlm.nih.gov/pubmed/34013166 http://dx.doi.org/10.26434/chemrxiv.14442785 |
Ejemplares similares
-
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
por: Kongsuphol, Patthara, et al.
Publicado: (2021) -
Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health
por: Miller, Eric, et al.
Publicado: (2015) -
Learned features of antibody-antigen binding affinity
por: Miller, Nathaniel L., et al.
Publicado: (2023) -
Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
por: Cheng, Hoi Lok, et al.
Publicado: (2022) -
On the Rapid Calculation of Binding Affinities for Antigen and Antibody Design and Affinity Maturation Simulations
por: Conti, Simone, et al.
Publicado: (2022)